Young adult cancer survivors have higher rates of mental distress, housing and food insecurity than peers with no cancer history

Benefits seen in health-related quality of life and anxiety

However, disparities exist among cancer survivors by race and health coverage

Top concerns include life expectancy, course of treatment, and pain

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy

About half of physicians would consider euthanasia as a good or very good option in a scenario of advanced cancer or Alzheimer disease

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors

Stronger effects seen for women from some racial/ethnic minority groups and with lower socioeconomic status